Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF $40.00
$40.00
× Placeholder Prevalence, Correlates, and Comorbidity of DSM-IV Antisocial Personality Syndromes and Alcohol and Specific Drug Use Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF $40.00
$40.00
× Placeholder Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder Triple-Bead Mixed Amphetamine Salts (SPD465), a Novel, Enhanced Extended-Release Amphetamine Formulation for the Treatment of Adults With ADHD: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness PDF $40.00
$40.00
× Placeholder Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record PDF $40.00
$40.00
× Placeholder Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients PDF $40.00
$40.00
× Placeholder GLP-1 Analogs Are Superior in Mediating Weight Loss But Not Glycemic Control in Diabetic Patients on Antidepressant Medications: A Retrospective Cohort Study PDF $40.00
$40.00
× Placeholder Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications PDF $40.00
$40.00
× Placeholder Resilience in Bipolar Disorder and Interrelationships With Psychopathology, Clinical Features, Psychosocial Functioning, and Mediational Roles: A Systematic Review PDF $40.00
$40.00
× Placeholder Primary Care-Mental Health Integration Programs in the Veterans Affairs Health System Serve a Different Patient Population Than Specialty Mental Health Clinics PDF $40.00
$40.00
× Placeholder Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study of 76 Patients PDF $40.00
$40.00
× Placeholder A Case of Psychosis After Use of a Detoxification Kit and a Review of Techniques, Risks, and Regulations Associated With the Subversion of Urine Drug Tests PDF $40.00
$40.00
× Placeholder A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder PDF $40.00
$40.00
× Placeholder The Epidemiology of Antisocial Behavioral Syndromes in Adulthood: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III PDF $40.00
$40.00
× Placeholder Quetiapine Addition to Serotonin Reuptake Inhibitor Treatment in Patients With Treatment-Refractory Obsessive-Compulsive Disorder: An Open-Label Study PDF $40.00
$40.00
× Placeholder Prediction of Response to Paroxetine and Venlafaxine by Serotonin-Related Genes in Obsessive-Compulsive Disorder in a Randomized, Double-Blind Trial PDF $40.00
$40.00
× Placeholder Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period PDF $40.00
$40.00
× Placeholder Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes PDF $40.00
$40.00
× Placeholder A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction PDF $40.00
$40.00
× Placeholder Impairment and Functioning in a Sample of Primary Care Patients With Generalized Anxiety Disorder: Results From the Primary Care Anxiety Project PDF $40.00
$40.00
× Placeholder Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $880.00
Total $880.00